355 related articles for article (PubMed ID: 30592483)
1. Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome.
Chen JY; He PC; Liu YH; Wei XB; Jiang L; Guo W; Duan CY; Guo YS; Yu XP; Li J; Li WS; Zhou YL; Lin CY; Luo JF; Yu DQ; Chen ZJ; Chen W; Chen YY; Guo ZQ; Geng QS; Tan N
JAMA Intern Med; 2019 Feb; 179(2):186-194. PubMed ID: 30592483
[TBL] [Abstract][Full Text] [Related]
2. Association of Parenteral Anticoagulation Therapy With Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Without Invasive Therapy: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project.
Liu YH; Fan HL; Zeng LH; Duan CY; Chen G; Chen PY; Zhao D; Liu J; Hao YC; He WF; Tao S; Wei XB; Jiang L; Guo W; Guo YS; Chen W; Li J; Hu YZ; Li WS; Chen YY; Luo JF; Zhou YL; Yu DQ; Han YL; Tan N; Chen JY; He PC
Clin Pharmacol Ther; 2021 Oct; 110(4):1119-1126. PubMed ID: 34287856
[TBL] [Abstract][Full Text] [Related]
3. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
[TBL] [Abstract][Full Text] [Related]
4. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Gupta T; Kolte D; Khera S; Harikrishnan P; Mujib M; Aronow WS; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107131
[TBL] [Abstract][Full Text] [Related]
5. Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Nicolau JC; Henry P; Kedev S; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
Circ Cardiovasc Interv; 2018 Jun; 11(6):e006084. PubMed ID: 29895599
[TBL] [Abstract][Full Text] [Related]
6. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
[TBL] [Abstract][Full Text] [Related]
7. Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
Yan Y; Guo J; Wang X; Wang G; Fan Z; Yin D; Wang Z; Zhang F; Tian C; Gong W; Liu J; Lu J; Li Y; Ma C; Vicaut E; Montalescot G; Nie S;
Circulation; 2024 Apr; 149(16):1258-1267. PubMed ID: 38406848
[TBL] [Abstract][Full Text] [Related]
8. Association of Anemia With Outcomes Among ST-Segment-Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention.
Moghaddam N; Wong GC; Cairns JA; Goodman SG; Perry-Arnesen M; Tocher W; Mackay M; Singer J; Lee T; Rao SV; Fordyce CB
Circ Cardiovasc Interv; 2018 Dec; 11(12):e007175. PubMed ID: 30562086
[TBL] [Abstract][Full Text] [Related]
9. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
Hahn JY; Song YB; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Kim J; Choi KH; Park TK; Lee JM; Yang JH; Choi JH; Choi SH; Gwon HC;
Lancet; 2018 Mar; 391(10127):1274-1284. PubMed ID: 29544699
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
Steg PG; Mehta SR; Pollack CV; Bode C; Cohen M; French WJ; Hoekstra J; Rao SV; Ruzyllo W; Ruiz-Nodar JM; Sabaté M; Widimsky P; Kiss RG; Navarro Estrada JL; Hod H; Kerkar P; Guneri S; Sezer M; Ruda M; Nicolau JC; Cavallini C; Ebrahim I; Petrov I; Kim JH; Jeong MH; Ramos Lopez GA; Laanmets P; Kovar F; Gaudin C; Fanouillere KC; Minini P; Hoffman EB; Moryusef A; Wiviott SD; Sabatine MS;
JAMA; 2013 Sep; 310(11):1145-55. PubMed ID: 23995608
[TBL] [Abstract][Full Text] [Related]
11. One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.
Danchin N; Puymirat E; Cayla G; Cottin Y; Coste P; Gilard M; Goldstein P; Braun F; Belle L; Montalescot G; Ferrières J; Schiele F; Simon T;
Circ Cardiovasc Interv; 2018 Sep; 11(9):e007241. PubMed ID: 30354592
[TBL] [Abstract][Full Text] [Related]
12. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
13. Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
Redfors B; Kirtane AJ; Pocock SJ; Ayele GM; Deliargyris EN; Mehran R; Stone GW; Généreux P
J Am Coll Cardiol; 2016 Dec; 68(24):2608-2618. PubMed ID: 27978944
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
[TBL] [Abstract][Full Text] [Related]
15. Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry.
Safley DM; Venkitachalam L; Kennedy KF; Cohen DJ
JACC Cardiovasc Interv; 2015 Oct; 8(12):1574-82. PubMed ID: 26493250
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic warfarin therapy after primary percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.
Le May MR; Acharya S; Wells GA; Burwash I; Chong AY; So DY; Glover CA; Froeschl MPV; Hibbert B; Marquis JF; Dick A; Blondeau M; Bernick J; Labinaz M
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):155-162. PubMed ID: 25616920
[TBL] [Abstract][Full Text] [Related]
17. Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO Trial.
Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Petrauskiene B; Henry P; Dorobantu M; French WJ; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
Circ Cardiovasc Interv; 2021 Jan; 14(1):e009759. PubMed ID: 33430604
[TBL] [Abstract][Full Text] [Related]
18. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
[TBL] [Abstract][Full Text] [Related]
20. Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.
Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Patel D; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28855222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
